机器学习在ARDS中的应用:重症医师的人工智能应用指南
本叙述性综述总结了人工智能(AI)在急性呼吸窘迫综合征(ARDS)和机械通气中的应用。利用电子健康记录、影像、生理波形和组学数据的机器学习模型在预测ARDS起病、早期诊断、优化管理和预测结局方面表现强劲,常等效或优于传统指南和评分。但多数模型仍限于研究场景,临床采用有限。挑战包括多数研究为回顾性、单中心且缺乏严格外部验证,以及数据质量与偏倚、校准不良、决策曲线分析稀缺、可解释性有限、缺乏前瞻性试验证明AI指导策略改善以患者为中心的结局。结论认为机器学习通过预测性和预后性富集及支持个体化通气护理,有潜力推进ARDS精准医学,但安全公平部署需要标准化方法、透明报告、多中心前瞻性验证和临床医生主导的治理。
要点
- 使用电子健康记录、影像、生理波形和组学数据的机器学习模型在预测ARDS起病、早期诊断、优化管理和预测结局方面表现强劲,常等效或优于传统指南和评分。
- 多数机器学习模型仍限于研究场景,临床采用有限。
- 多数研究为回顾性、单中心且缺乏严格外部验证,限制泛化性和真实世界影响。
- 挑战还包括数据质量与偏倚、校准不良、决策曲线分析稀缺、可解释性有限,以及缺乏前瞻性试验证明AI指导策略改善以患者为中心的结局。
- 安全公平部署需要标准化方法、透明报告、多中心前瞻性验证和临床医生主导的治理,以确保AI增强而非替代专家临床判断。
适用人群与场景
- 重症监护中ARDS患者,用于早期风险预测、诊断、表型分型、管理和结局预测。
研究设计与关键结果
- 叙述性综述:使用电子健康记录、影像、生理波形和组学数据的机器学习模型在预测ARDS起病、早期诊断、优化管理和预测结局方面表现强劲,常等效或优于传统指南和评分。
- 多数模型仍限于研究场景,临床采用有限。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:多数研究为回顾性、单中心且缺乏严格外部验证,限制泛化性和真实世界影响;数据质量与偏倚、校准不良、决策曲线分析稀缺、可解释性有限;缺乏前瞻性试验证明AI指导策略改善以患者为中心的结局。
对床旁实践的改变
- 作者认为机器学习通过预测性和预后性富集及支持个体化通气护理,有潜力推进ARDS精准医学。
- 作者认为安全公平部署需要标准化方法、透明报告、多中心前瞻性验证和临床医生主导的治理,以确保AI增强而非替代专家临床判断。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute Respiratory Distress Syndrome (ARDS) is a heterogeneous, life-threatening condition with persistent diagnostic uncertainty, limited causal treatments, and high mortality in intensive care. ARDS management remains largely supportive, and conventional scores and trial designs have struggled to account for its biological and clinical heterogeneity. OBJECTIVE: This narrative review summarizes current and emerging applications of Artificial Intelligence (AI) in ARDS and mechanical ventilation. It focuses on how Machine Learning (ML) can refine early risk prediction, diagnosis, phenotyping, management and outcome prediction, while outlining the strengths, weaknesses and nuances of these applications. FINDINGS: ML models using electronic health records, imaging, physiological waveforms and omics data show strong performance for predicting ARDS onset, enabling early diagnosis, optimising management and forecasting outcomes. These models show performance equivalent to and often outperform traditional guidelines and scores. However, most of these models remain limited to the research setting and show limited clinical adoption. CHALLENGES: Most studies are retrospective, single-center and lack rigorous external validation, limiting generalizability and real-world impact. Additional challenges include data quality and bias, poor calibration and scarce decision-curve analyses, limited interpretability, and the absence of prospective trials demonstrating that AI-guided strategies improve patient-centered outcomes. CONCLUSION: ML has substantial potential to advance precision medicine in ARDS by enabling predictive and prognostic enrichment and supporting personalized ventilatory care. Its safe and equitable deployment, however, requires standardized methodology, transparent reporting, multicenter prospective validation, and clinician-led governance to ensure that AI augments rather than replaces expert clinical judgment.
参考来源
- Lombardi R, Chaturvedi M, Jozwiak M, et al. Machine learning in ARDS: an intensivist's guide to artificial intelligence applications. Crit Care. 2026. PMID: 41826985. doi:10.1186/s13054-026-05928-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。